Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Wiley-Blackwell"" wg kryterium: PB

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 10870860
Tytuł:
A real-world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy or failed in previous amoxicillin-containing therapies.
Autorzy:
Gao W; GI Department, Peking University First Hospital, Beijing, China.
Xu Y; GI Department, Peking University First Hospital, Beijing, China.
Liu J; GI Department, Peking University First Hospital, Beijing, China.
Wang X; GI Department, Peking University First Hospital, Beijing, China.
Dong X; GI Department, Peking University First Hospital, Beijing, China.
Teng G; GI Department, Peking University First Hospital, Beijing, China.
Liu B; GI Department, Peking University First Hospital, Beijing, China.
Dong J; GI Department, Peking University First Hospital, Beijing, China.
Ge C; GI Department, Peking University First Hospital, Beijing, China.
Ye H; TCM and Integrative Medicine Department, Peking University First Hospital, Beijing, China.
Zhang X; TCM and Integrative Medicine Department, Peking University First Hospital, Beijing, China.
Cheng H; GI Department, Peking University First Hospital, Beijing, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12947. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Hypersensitivity*
Humans ; Amoxicillin/therapeutic use ; Feasibility Studies ; Anti-Bacterial Agents/therapeutic use ; Tetracycline/therapeutic use ; Penicillins/therapeutic use ; Drug Therapy, Combination ; Treatment Outcome ; Clarithromycin/therapeutic use ; Proton Pump Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection.
Autorzy:
Zhai K; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Gong Y; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Sun L; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
He L; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xue Z; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Yang Y; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Fang M; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhang J; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12955. Date of Electronic Publication: 2023 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Helicobacter pylori*
Helicobacter Infections*/prevention & control
Animals ; Female ; Immunodominant Epitopes ; Chickens ; Tandem Mass Spectrometry ; Antibodies, Bacterial ; DNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Regulatory B cells (Bregs) in Helicobacter pylori chronic infection.
Autorzy:
Hassuna NA; Medical Microbiology and Immunology Department, Faculty of Medicine, Minia University, Minia, Egypt.
Hussien SS; Medical Microbiology and Immunology Department, Faculty of Medicine, Minia University, Minia, Egypt.
Abdelhakeem M; Clinical Pathology Department, Faculty of Medicine, Minia University, Minia, Egypt.
Aboalela A; Minia International Hospital, Minia, Egypt.
Ahmed E; Internal Medicine Department, Faculty of Medicine, Minia University, Minia, Egypt.
Abdelrahim SS; Medical Microbiology and Immunology Department, Faculty of Medicine, Minia University, Minia, Egypt.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12951. Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Helicobacter pylori*/genetics
Helicobacter Infections*/microbiology
B-Lymphocytes, Regulatory*/pathology
Adult ; Humans ; Bacterial Proteins/genetics ; Antigens, Bacterial/genetics ; Persistent Infection ; Genotype ; Virulence Factors/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication.
Autorzy:
Guan JL; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Han YY; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang MR; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xia SH; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li JY; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang MY; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhao K; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Feng LN; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Y; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Dong RN; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liao JZ; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li PY; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Gastroenterology, Wenchang People's Hospital, Wenchang, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12953. Date of Electronic Publication: 2023 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Helicobacter pylori*
Helicobacter Infections*/drug therapy
Humans ; Anti-Bacterial Agents/therapeutic use ; Drug Therapy, Combination ; Amoxicillin/therapeutic use ; Proton Pump Inhibitors/therapeutic use ; Body Size ; Body Weight ; Treatment Outcome ; Clarithromycin/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cardia and non-cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta-analysis, and estimation of population attributable fraction.
Autorzy:
Han Z; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Liu J; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Zhang W; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Kong Q; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wan M; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Lin M; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Lin B; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Ding Y; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Duan M; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Li Y; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Zuo X; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Li Y; Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Robot engineering laboratory for precise diagnosis and therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12950. Date of Electronic Publication: 2023 Jan 16.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article; Review
MeSH Terms:
Stomach Neoplasms*/epidemiology
Helicobacter pylori*
Helicobacter Infections*/epidemiology
Humans ; Risk ; Asia, Eastern ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Critical appraisal of international guidelines for the management of Helicobacter pylori infection in case of dyspepsia.
Autorzy:
Collin A; Lyon Sud Faculty of Medecine, Claude Bernard Lyon 1 University, Lyon, France.; Gastroenterology Department, Alpes-Léman Hospital, Contamine sur Arve, France.
Mion F; Hospices Civils de Lyon, Digestive Physiology Department, INSERM U1032, University of Lyon, Lyon, France.
Kefleyesus A; Department of Visceral Surgery and University of Lausanne, Lausanne University Hospital, Lausanne, Switzerland.; Department of Surgical Oncology, Lyon Sud University Hospital, Pierre-Bénite, France.
Beets C; Gastroenterology Department, Alpes-Léman Hospital, Contamine sur Arve, France.
Jaafari N; URC Pierre-Denicker, Psychiatry Department, CIC Inserm U802, Inserm U1084, Experimental and Clinical Neurosciences Laboratory, Faculty of Medecine of Poitiers, Research Team, CNRS 3557, Henri-Laborit Hospital, Poitiers University Hospital, Poitiers, France.
Boussageon R; Claude Bernard Lyon 1 University, CNRS, UMR 5558, LBBE, EMET, Lyon, France.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12952.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Dyspepsia*/diagnosis
Anti-Ulcer Agents*/therapeutic use
Humans ; Clarithromycin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Amoxicillin/therapeutic use ; Drug Therapy, Combination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Helicobacter pylori treatment knowledge, access and barriers: A cross-sectional study.
Autorzy:
Bailey KS; Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
Brown HE; Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
Lekic V; Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona, USA.
Pradeep K; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona, USA.
Merchant JL; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona, USA.
Harris RB; Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12954. Date of Electronic Publication: 2023 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Stomach Neoplasms*/microbiology
Humans ; Cross-Sectional Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial.
Autorzy:
Zhang Y; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Suo B; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Tian X; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Zhang H; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Lu H; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Yao X; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Li C; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Ren X; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Zhou L; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Song Z; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12956. Date of Electronic Publication: 2023 Feb 08.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Hypersensitivity*
Humans ; Penicillins/adverse effects ; Bismuth/therapeutic use ; Metronidazole/therapeutic use ; Cefuroxime/pharmacology ; Cefuroxime/therapeutic use ; Minocycline/pharmacology ; Minocycline/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Tetracycline/therapeutic use ; Medication Adherence ; Drug Therapy, Combination ; Treatment Outcome ; Amoxicillin/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post-treatment of opisthorchiasis: Correspondence.
Autorzy:
Mungmunpuntipantip R; Private Academic Consultant, Bangkok, Thailand.
Wiwanitkit V; Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria.; Dr. DY Patil Medical College - Dr. D. Y. Patil Vidyapeeth, Pune, India.; Parasitic Disease Research Unit, Suranaree University of Technology, Nakorn Rachasima, Thailand.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12949. Date of Electronic Publication: 2023 Jan 12.
Typ publikacji:
Letter; Comment
MeSH Terms:
Opisthorchiasis*
Helicobacter pylori*
Helicobacter Infections*
Opisthorchis*
Animals ; Humans ; Fibrosis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intravenous metronidazole-, levofloxacin-containing triple therapy for treating patients with Helicobacter pylori-related active peptic ulcer complications: A pilot study.
Autorzy:
Zhang W; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gui Q; Department of Emergency Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen J; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yu D; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Su W; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhu C; Department of Emergency Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liang X; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lu H; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12946. Date of Electronic Publication: 2023 Jan 12.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Peptic Ulcer*/drug therapy
Humans ; Amoxicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Drug Therapy, Combination ; Esomeprazole/therapeutic use ; Levofloxacin/pharmacology ; Metronidazole/therapeutic use ; Pilot Projects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Network meta-analysis of different dosages of esomeprazole and rabeprazole for the treatment of Helicobacter pylori.
Autorzy:
Wang Y; Department of Elderly Digestive, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.
Dai X; Department of Elderly Digestive, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.
Gao C; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.; Department of Gastroenterology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Yang X; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Apr; Vol. 28 (2), pp. e12948. Date of Electronic Publication: 2023 Jan 16.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Helicobacter pylori*
Helicobacter Infections*/drug therapy
Humans ; Esomeprazole/therapeutic use ; Rabeprazole/therapeutic use ; Network Meta-Analysis ; Proton Pump Inhibitors/therapeutic use ; Drug Therapy, Combination ; Treatment Outcome ; Anti-Bacterial Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.
Autorzy:
Tian XL; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Suo BJ; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Zhang H; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Lu HP; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Li CL; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Zhang YX; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Ren XL; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Yao XY; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Zhou LY; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Song ZQ; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Feb; Vol. 28 (1), pp. e12935. Date of Electronic Publication: 2022 Nov 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Helicobacter pylori*
Helicobacter Infections*/drug therapy
Humans ; Amoxicillin/adverse effects ; Metronidazole/adverse effects ; Bismuth/adverse effects ; Esomeprazole/therapeutic use ; Anti-Bacterial Agents/adverse effects ; Tetracycline/adverse effects ; Drug Therapy, Combination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A comprehensive evaluation of an animal model for Helicobacter pylori-associated stomach cancer: Fact and controversy.
Autorzy:
Amalia R; Helicobacter pylori and Microbiota Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.
Panenggak NSR; Helicobacter pylori and Microbiota Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.
Doohan D; Helicobacter pylori and Microbiota Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.; Department of Anatomy, Histology and Pharmacology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Rezkitha YAA; Helicobacter pylori and Microbiota Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.; Department of Internal Medicine, Faculty of Medicine, Universitas Muhammadiyah Surabaya, Surabaya, Indonesia.
Waskito LA; Helicobacter pylori and Microbiota Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.; Department of Physiology and Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Syam AF; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Lubis M; Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
Yamaoka Y; Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan.; Department of Medicine, Gastroenterology and Hepatology Section, Baylor College of Medicine, Texas, Houston, USA.
Miftahussurur M; Helicobacter pylori and Microbiota Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.; Division of Gastroentero-Hepatology, Department of Internal Medicine, Faculty of Medicine-Dr. Soetomo Teaching Hospital, Universitas Airlangga, Surabaya, Indonesia.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Feb; Vol. 28 (1), pp. e12943. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Stomach Neoplasms*/pathology
Helicobacter pylori*
Helicobacter Infections*/complications
Helicobacter Infections*/pathology
Animals ; Mice ; Gerbillinae ; Disease Models, Animal ; Mice, Transgenic ; Gastric Mucosa/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Helicobacter pylori regulated microRNA map of human gastric cells.
Autorzy:
Ramesh P; Centre for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.
Babu S; Centre for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.
Ammankallu S; Centre for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.
Codi JAK; Department of Surgical Oncology, Yenepoya Medical College, Yenepoya (Deemed to be University), Mangalore, India.
Prasad TSK; Centre for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.
Raju R; Centre for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.; Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University), Mangalore, India.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Feb; Vol. 28 (1), pp. e12941. Date of Electronic Publication: 2022 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
Helicobacter pylori*/physiology
Helicobacter Infections*/microbiology
Stomach Neoplasms*/pathology
Animals ; Humans ; Retrospective Studies ; RNA, Messenger ; Gastric Mucosa/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial.
Autorzy:
Lu L; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wang Y; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ye J; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Han Y; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lou G; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Li Y; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yan H; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Du Q; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Feb; Vol. 28 (1), pp. e12940. Date of Electronic Publication: 2022 Dec 01.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Humans ; Esomeprazole ; Anti-Bacterial Agents/adverse effects ; Bismuth/therapeutic use ; Furazolidone ; Drug Therapy, Combination ; Amoxicillin/therapeutic use ; Treatment Outcome ; Proton Pump Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of guidelines for diagnosis and treatment of Helicobacter pylori infection.
Autorzy:
Ji YH; Department of Gastrointestinal Surgery, Second Affiliated Hospital of Kunming Medical University/Second Faculty of Clinical Medicine, Kunming Medical University, Kunming, China.
Shi YM; Department of Gastroenterology, Second Affiliated Hospital of Kunming Medical University/Second Faculty of Clinical Medicine, Kunming Medical University, Kunming, China.
Hei QW; Department of Gastrointestinal Surgery, Second Affiliated Hospital of Kunming Medical University/Second Faculty of Clinical Medicine, Kunming Medical University, Kunming, China.
Sun JM; Department of Gastrointestinal Surgery, Second Affiliated Hospital of Kunming Medical University/Second Faculty of Clinical Medicine, Kunming Medical University, Kunming, China.
Yang XF; Department of Gastrointestinal Surgery, Second Affiliated Hospital of Kunming Medical University/Second Faculty of Clinical Medicine, Kunming Medical University, Kunming, China.
Wu T; Department of infectious diseases, The First People's Hospital of Kunming, Kunming, China.
Sun DL; Department of Gastrointestinal Surgery, Second Affiliated Hospital of Kunming Medical University/Second Faculty of Clinical Medicine, Kunming Medical University, Kunming, China.
Qi YX; Department of Gastrointestinal Surgery, Second Affiliated Hospital of Kunming Medical University/Second Faculty of Clinical Medicine, Kunming Medical University, Kunming, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Feb; Vol. 28 (1), pp. e12937. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Helicobacter Infections*/diagnosis
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Humans ; Drug Therapy, Combination ; Proton Pump Inhibitors/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Bismuth/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Helicobacter pylori-positive chronic atrophic gastritis and cellular senescence.
Autorzy:
Zheng SY; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhu L; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wu LY; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Liu HR; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Shanghai Research Institute of Acupuncture and Meridian, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Ma XP; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Shanghai Research Institute of Acupuncture and Meridian, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Li Q; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wu MD; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang WJ; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Li J; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wu HG; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Shanghai Research Institute of Acupuncture and Meridian, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Feb; Vol. 28 (1), pp. e12944. Date of Electronic Publication: 2022 Dec 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Gastritis, Atrophic*/pathology
Helicobacter pylori*
Helicobacter Infections*/complications
Helicobacter Infections*/pathology
Stomach Neoplasms*/pathology
Humans ; Gastric Mucosa/pathology ; Cellular Senescence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta-analysis and critical analysis.
Autorzy:
Rokkas T; Gastroenterology Clinic, Henry Dunant Hospital, Athens, Greece.; Medical School, European University of Cyprus, Nicosia, Cyprus.
Ekmektzoglou K; Gastroenterology Clinic, Henry Dunant Hospital, Athens, Greece.; Medical School, European University of Cyprus, Nicosia, Cyprus.
Graham DY; Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Feb; Vol. 28 (1), pp. e12936. Date of Electronic Publication: 2022 Dec 01.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:
Helicobacter Infections*/drug therapy
Helicobacter Infections*/microbiology
Helicobacter pylori*
Humans ; Anti-Bacterial Agents/therapeutic use ; Drug Therapy, Combination ; Odds Ratio
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transmission routes and patterns of helicobacter pylori.
Autorzy:
Duan M; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Li Y; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Liu J; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Zhang W; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Dong Y; Center for Reproductive Medicine, Shandong University, Jinan, China.
Han Z; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Wan M; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Lin M; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Lin B; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Kong Q; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Ding Y; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Yang X; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.
Zuo X; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Li Y; Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, China.; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, China.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Feb; Vol. 28 (1), pp. e12945. Date of Electronic Publication: 2023 Jan 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Helicobacter pylori*
Helicobacter Infections*/microbiology
Stomach Neoplasms*
Peptic Ulcer*
Child ; Animals ; Humans ; Feces/microbiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea.
Autorzy:
Lee JW; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
Kim N; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Choi SI; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Jang JY; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Song CH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Nam RH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Lee DH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2023 Feb; Vol. 28 (1), pp. e12939. Date of Electronic Publication: 2022 Dec 07.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Helicobacter Infections*/drug therapy
Helicobacter Infections*/epidemiology
Helicobacter pylori*
Humans ; Amoxicillin/therapeutic use ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Clarithromycin/pharmacology ; Clarithromycin/therapeutic use ; Drug Resistance, Bacterial ; Levofloxacin/pharmacology ; Levofloxacin/therapeutic use ; Metronidazole/therapeutic use ; Microbial Sensitivity Tests ; Moxifloxacin ; Prevalence ; Republic of Korea/epidemiology ; Tertiary Care Centers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 10870860

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies